Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population

NCT ID: NCT01148563

Last Updated: 2024-01-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

136 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-03-31

Study Completion Date

2011-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to see whether a tele-health intervention can improve health, functioning status, emotional status, quality of life, and patient satisfaction for patients with Congestive Heart Failure (CHF) and to examine the cost benefits of this intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congestive Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care

The Standard Care group will continue regular LSU HCSD disease management care for heart failure patients with no additional intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Tele-health Monitoring Group

The tele-monitoring intervention group will have the continual standard care from their physician plus the tele-health monitoring. The tele-health monitor will collect the following data: weight, blood pressure, pulse oximetry, pulse rate, \& patient responses to disease-specific questions regarding changes in state of health for 6 months.

Group Type ACTIVE_COMPARATOR

Tele-health Monitoring

Intervention Type DEVICE

Daily tele-health monitoring data will be collected from randomized participants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tele-health Monitoring

Daily tele-health monitoring data will be collected from randomized participants.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* equal to or greater than 18 years old
* 1 + past CHF diagnosis in LSU database, with history of CHF diagnosis extending back for 12 months
* LSU primary care or chronic disease clinic patient for equal or greater than 6 months.
* On CHF medication for equal to or greater than 6 months
* Have had a past echocardiogram
* Mental competency to consent and participate (determined by clinical judgment and chart abstraction)
* Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use)
* Currently-working conventional telephone line at primary residence
* Grounded electrical power supply at primary residence
* Anticipation of remaining in the LSU HCSD patient population for the next year
* Not on home oxygen therapy
* No planned surgery within the next six months
* Living at home (not institutionalized)
* No history of major organ transplant
* No diagnosis of metastatic or inoperable cancer
* Not under treatment for cancer
* Not under treatment for end-stage renal disease or end-stage liver disease
* 1 + emergency department visit or inpatient stay in past 12 months

Exclusion Criteria

* Are on home oxygen
* Have a planned surgery within the next 6 months
* Have a history of major organ transplant
* Have a diagnosis of metastatic or inoperable cancer
* Are under treatment for cancer
* Are under treatment for end-stage renal disease or end-stage liver disease
* Have HIV/AIDS
* Have a cognitive condition, such as Alzheimer's or dementia that would make it difficult for you to understand how to use the tele-health device.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pennington Biomedical Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lee Arcement, MD

Role: PRINCIPAL_INVESTIGATOR

Louisiana State University Health Care Services Division

Michael Kaiser, MD

Role: STUDY_CHAIR

Louisiana State University Health Care Services Division

Ronald Horswell, PhD

Role: STUDY_CHAIR

Louisiana State University Health Care Services Division

Jay Besse, BS

Role: STUDY_CHAIR

Louisiana State University Health Care Services Divison

Timothy S. Church, MD, MPH, PhD

Role: STUDY_CHAIR

Pennington Biomedical Research Center

Valerie H. Myers, PhD

Role: STUDY_CHAIR

Pennington Biomedical Research Center

Donna H. Ryan, MD

Role: STUDY_CHAIR

Pennington Biomedical Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Earl K. Long Medical Center

Baton Rouge, Louisiana, United States

Site Status

Leonard J. Chabert Medical Center

Houma, Louisiana, United States

Site Status

University Medical Center

Lafayette, Louisiana, United States

Site Status

WO Moss Regional Medical Center

Lake Charles, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PBRC 29003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The HEARTFELT Study
NCT06222099 RECRUITING NA
Mobile App for Heart Failure
NCT05668000 COMPLETED NA